Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome

Saskia Ingen-Housz-Oro; Florent Amatore; Tarik El Aarbaoui; Adèle de Masson; Anne Pham-Ledard; Olivier Dereure; Gaëlle Quereux; Sarah Faiz; Marine de Vicq de Cumptich; Caroline Ram-Wolff; Raphaël Janela-Lapert; Emmanuella Guenova; Coralie Lheure; Yannick Le Corre; Henri Adamski; Nathalie Bonnet; Florent Grange; Laura Troin; Sofia Tzoumpa; Martine Bagot; Marie Beylot-Barry

doi:10.1093/bjd/ljag211

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome

Saskia Ingen-Housz-Oro^*
, Florent Amatore
, Tarik El Aarbaoui
, Adèle de Masson
, Anne Pham-Ledard
, Olivier Dereure
, Gaëlle Quereux
, Sarah Faiz
, Marine de Vicq de Cumptich
, Caroline Ram-Wolff
, Raphaël Janela-Lapert
, Emmanuella Guenova
, Coralie Lheure
, Yannick Le Corre
, Henri Adamski
, Nathalie Bonnet
, Florent Grange
, Laura Troin
, Sofia Tzoumpa
, Martine Bagot

Marie Beylot-Barry

^*Corresponding author for this work

Department of Translational Immunodermatology

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	512-514
Number of pages	3
Journal	The British Journal of Dermatology
Volume	195
Issue number	3
Early online date	23 Jul 2026
DOIs	https://doi.org/10.1093/bjd/ljag211
Publication status	Published - 18 Aug 2026

Fields of science

301902 Immunology
302 Clinical Medicine
302011 Dermatology

Access to Document

10.1093/bjd/ljag211

Cite this

Ingen-Housz-Oro, S., Amatore, F., El Aarbaoui, T., de Masson, A., Pham-Ledard, A., Dereure, O., Quereux, G., Faiz, S., de Vicq de Cumptich, M., Ram-Wolff, C., Janela-Lapert, R., Guenova, E., Lheure, C., Le Corre, Y., Adamski, H., Bonnet, N., Grange, F., Troin, L., Tzoumpa, S., ... Beylot-Barry, M. (2026). Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome. The British Journal of Dermatology, 195(3), 512-514. https://doi.org/10.1093/bjd/ljag211

@article{30ebb2ccdba4497897f855461a7f1b79,

title = "Durable remission with no survival reduction after mogamulizumab discontinuation in S{\'e}zary syndrome",

author = "Saskia Ingen-Housz-Oro and Florent Amatore and \{El Aarbaoui\}, Tarik and \{de Masson\}, Ad{\`e}le and Anne Pham-Ledard and Olivier Dereure and Ga{\"e}lle Quereux and Sarah Faiz and \{de Vicq de Cumptich\}, Marine and Caroline Ram-Wolff and Rapha{\"e}l Janela-Lapert and Emmanuella Guenova and Coralie Lheure and \{Le Corre\}, Yannick and Henri Adamski and Nathalie Bonnet and Florent Grange and Laura Troin and Sofia Tzoumpa and Martine Bagot and Marie Beylot-Barry",

year = "2026",

month = aug,

day = "18",

doi = "10.1093/bjd/ljag211",

language = "English",

volume = "195",

pages = "512--514",

journal = "The British Journal of Dermatology",

issn = "1365-2133",

number = "3",

}

Ingen-Housz-Oro, S, Amatore, F, El Aarbaoui, T, de Masson, A, Pham-Ledard, A, Dereure, O, Quereux, G, Faiz, S, de Vicq de Cumptich, M, Ram-Wolff, C, Janela-Lapert, R, Guenova, E, Lheure, C, Le Corre, Y, Adamski, H, Bonnet, N, Grange, F, Troin, L, Tzoumpa, S, Bagot, M & Beylot-Barry, M 2026, 'Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome', The British Journal of Dermatology, vol. 195, no. 3, pp. 512-514. https://doi.org/10.1093/bjd/ljag211

TY - JOUR

T1 - Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome

AU - Ingen-Housz-Oro, Saskia

AU - Amatore, Florent

AU - El Aarbaoui, Tarik

AU - de Masson, Adèle

AU - Pham-Ledard, Anne

AU - Dereure, Olivier

AU - Quereux, Gaëlle

AU - Faiz, Sarah

AU - de Vicq de Cumptich, Marine

AU - Ram-Wolff, Caroline

AU - Janela-Lapert, Raphaël

AU - Guenova, Emmanuella

AU - Lheure, Coralie

AU - Le Corre, Yannick

AU - Adamski, Henri

AU - Bonnet, Nathalie

AU - Grange, Florent

AU - Troin, Laura

AU - Tzoumpa, Sofia

AU - Bagot, Martine

AU - Beylot-Barry, Marie

PY - 2026/8/18

Y1 - 2026/8/18

UR - https://www.scopus.com/pages/publications/105047559192

U2 - 10.1093/bjd/ljag211

DO - 10.1093/bjd/ljag211

M3 - Article

C2 - 42490360

SN - 1365-2133

VL - 195

SP - 512

EP - 514

JO - The British Journal of Dermatology

JF - The British Journal of Dermatology

IS - 3

ER -

Durable remission with no survival reduction after mogamulizumab discontinuation in Sézary syndrome

Fields of science

Access to Document

Other files and links

Cite this